LifeMD Partners With AT&T to Offer Virtual Healthcare to 29 Million Customers

Direct-to-consumer telehealth provider LifeMD, Inc. (NASDAQ: LFMD) has entered into an exclusive healthcare collaboration with AT&T Inc. (NYSE: T) to offer virtual healthcare membership benefits to AT&T customers, as reported by Yahoo Finance (https://finance.yahoo.com/healthcare/articles/lifemd-lfmd-secures-t-partnership-184302502.html). Under the agreement, announced Sept. 15, LifeMD is waiving its standard $19 monthly membership fee for eligible AT&T wireless and fiber broadband customers across an initial footprint of 11 states. The initial rollout covers approximately 29 million eligible adult customers aged 18 and older, subject to state regulations and service-specific restrictions.

The partnership establishes a direct distribution channel for LifeMD through AT&T’s website, mobile app, and customer-benefits program. While the recurring membership fee is waived, customers are required to enroll to access the platform. Following the initial multi-state phase, the companies plan a nationwide expansion in January 2027 that would extend eligibility to more than 100 million AT&T customers across the United States.

Although membership is free to enrolled customers, individual clinical consultations, prescriptions, and ancillary services remain separately payable. Announced pricing starts at $29 for message-based care, $49 for video-based urgent and primary care visits, and $79 for specialty care. Patients may pay using discounted cash-pay rates or apply commercial insurance and Medicare for eligible visits and prescriptions.

According to a Form 8-K filed by LifeMD on Sept. 15, the company will initially pay AT&T Services, Inc. a fixed fee per lead, with subsequent compensation terms subject to future negotiation. The regulatory filing does not disclose the monetary amount of the per-lead fee or include minimum patient or revenue commitments.

For LifeMD, the arrangement represents an opportunity to convert broad distribution access into recurring demand for paid care while reducing reliance on direct digital advertising. However, commercial profitability will depend on conversion rates from free enrollments to paid consultations, as well as repeat usage across primary care and chronic-condition management to offset clinician, support, and pharmacy fulfillment costs.

The underlying agreement carries an initial term of one year with automatic annual renewals, unless either party provides 90 days' written notice of non-renewal, alongside standard provisions for earlier termination. Separately, hedge fund tracker Insider Monkey reported that 15 hedge funds held positions in LifeMD at the end of the second quarter of 2026, up from 8 funds in the prior quarter.